In8bio Reconciled Depreciation vs Net Income From Continuing Ops Analysis

INAB Stock

USD 0.31 0.01 3.33%

In8bio financial indicator trend analysis is infinitely more than just investigating In8bio Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether In8bio Inc is a good investment. Please check the relationship between In8bio Reconciled Depreciation and its Net Income From Continuing Ops accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Reconciled Depreciation vs Net Income From Continuing Ops

Reconciled Depreciation vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of In8bio Inc Reconciled Depreciation account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have pay attention.

The correlation between In8bio's Reconciled Depreciation and Net Income From Continuing Ops is -0.92. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of In8bio Inc, assuming nothing else is changed. The correlation between historical values of In8bio's Reconciled Depreciation and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of In8bio Inc are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Reconciled Depreciation i.e., In8bio's Reconciled Depreciation and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

-0.92

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Reconciled Depreciation

Net Income From Continuing Ops

Most indicators from In8bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into In8bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Enterprise Value is expected to grow to about 39.9 M, whereas Selling General Administrative is forecasted to decline to about 7.8 M.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	788K	1.1M	2.5M	2.6M
Total Operating Expenses	14.7M	28.5M	30.3M	16.3M

Reconciled Depreciation Total Operating Expenses

In8bio fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Net Working Capital
Total Assets		0.85	0.99	0.85	0.74	-0.91	-0.78	0.56	0.97	0.8	0.36	0.43	0.97	-0.4	-0.4	0.78	0.71	-0.4	0.83	0.84	0.82	0.87	0.74	0.98	-0.33	0.95
Total Current Liabilities	0.85		0.76	0.8	0.9	-0.57	-0.89	0.84	0.69	0.99	0.4	0.42	0.69	-0.47	-0.47	0.86	0.88	-0.47	0.88	0.85	0.98	0.7	0.89	0.74	-0.3	0.65
Total Stockholder Equity	0.99	0.76		0.8	0.64	-0.96	-0.71	0.44	0.99	0.7	0.37	0.45	0.99	-0.37	-0.37	0.73	0.61	-0.37	0.76	0.79	0.72	0.85	0.65	1.0	-0.28	0.99
Net Tangible Assets	0.85	0.8	0.8		0.91	-0.68	-0.91	0.61	0.76	0.82	-0.01	0.06	0.76	-0.67	-0.67	0.71	0.85	-0.67	0.84	0.97	0.84	0.97	0.92	0.8	-0.71	0.75
Property Plant And Equipment Net	0.74	0.9	0.64	0.91		-0.44	-0.94	0.83	0.56	0.93	0.11	0.15	0.56	-0.68	-0.68	0.72	0.93	-0.68	0.87	0.93	0.94	0.79	1.0	0.62	-0.58	0.53
Net Debt	-0.91	-0.57	-0.96	-0.68	-0.44		0.56	-0.21	-0.99	-0.49	-0.41	-0.49	-0.99	0.32	0.32	-0.62	-0.38	0.32	-0.57	-0.66	-0.51	-0.76	-0.46	-0.97	0.16	-0.99
Retained Earnings	-0.78	-0.89	-0.71	-0.91	-0.94	0.56		-0.66	-0.65	-0.87	-0.27	-0.31	-0.65	0.8	0.8	-0.85	-0.8	0.8	-0.75	-0.98	-0.88	-0.79	-0.96	-0.7	0.47	-0.62
Accounts Payable	0.56	0.84	0.44	0.61	0.83	-0.21	-0.66		0.35	0.89	0.2	0.21	0.35	-0.26	-0.26	0.59	0.87	-0.26	0.88	0.62	0.88	0.48	0.79	0.42	-0.32	0.31
Cash	0.97	0.69	0.99	0.76	0.56	-0.99	-0.65	0.35		0.62	0.38	0.46	1.0	-0.34	-0.34	0.69	0.52	-0.34	0.69	0.74	0.64	0.82	0.57	1.0	-0.24	1.0
Non Current Assets Total	0.8	0.99	0.7	0.82	0.93	-0.49	-0.87	0.89	0.62		0.27	0.28	0.62	-0.44	-0.44	0.78	0.94	-0.44	0.91	0.84	1.0	0.71	0.91	0.68	-0.4	0.58
Non Currrent Assets Other	0.36	0.4	0.37	-0.01	0.11	-0.41	-0.27	0.2	0.38	0.27		0.99	0.38	-0.18	-0.18	0.48	-0.07	-0.18	0.09	0.16	0.23	-0.09	0.12	0.36	0.7	0.33
Other Assets	0.43	0.42	0.45	0.06	0.15	-0.49	-0.31	0.21	0.46	0.28	0.99		0.46	-0.22	-0.22	0.51	-0.05	-0.22	0.14	0.21	0.25	-0.01	0.16	0.44	0.65	0.41
Cash And Short Term Investments	0.97	0.69	0.99	0.76	0.56	-0.99	-0.65	0.35	1.0	0.62	0.38	0.46		-0.34	-0.34	0.69	0.52	-0.34	0.69	0.74	0.64	0.82	0.57	1.0	-0.24	1.0
Net Receivables	-0.4	-0.47	-0.37	-0.67	-0.68	0.32	0.8	-0.26	-0.34	-0.44	-0.18	-0.22	-0.34		1.0	-0.54	-0.38	1.0	-0.29	-0.77	-0.45	-0.53	-0.73	-0.36	0.38	-0.32
Common Stock Total Equity	-0.4	-0.47	-0.37	-0.67	-0.68	0.32	0.8	-0.26	-0.34	-0.44	-0.18	-0.22	-0.34	1.0		-0.54	-0.38	1.0	-0.29	-0.77	-0.45	-0.53	-0.73	-0.36	0.38	-0.32
Common Stock Shares Outstanding	0.78	0.86	0.73	0.71	0.72	-0.62	-0.85	0.59	0.69	0.78	0.48	0.51	0.69	-0.54	-0.54		0.65	-0.54	0.67	0.81	0.81	0.63	0.74	0.73	-0.19	0.65
Non Current Liabilities Total	0.71	0.88	0.61	0.85	0.93	-0.38	-0.8	0.87	0.52	0.94	-0.07	-0.05	0.52	-0.38	-0.38	0.65		-0.38	0.93	0.82	0.95	0.78	0.9	0.59	-0.66	0.5
Inventory	-0.4	-0.47	-0.37	-0.67	-0.68	0.32	0.8	-0.26	-0.34	-0.44	-0.18	-0.22	-0.34	1.0	1.0	-0.54	-0.38		-0.29	-0.77	-0.45	-0.53	-0.73	-0.36	0.38	-0.32
Other Current Assets	0.83	0.88	0.76	0.84	0.87	-0.57	-0.75	0.88	0.69	0.91	0.09	0.14	0.69	-0.29	-0.29	0.67	0.93	-0.29		0.8	0.93	0.81	0.84	0.75	-0.53	0.68
Other Stockholder Equity	0.84	0.85	0.79	0.97	0.93	-0.66	-0.98	0.62	0.74	0.84	0.16	0.21	0.74	-0.77	-0.77	0.81	0.82	-0.77	0.8		0.87	0.9	0.95	0.78	-0.59	0.72
Total Liab	0.82	0.98	0.72	0.84	0.94	-0.51	-0.88	0.88	0.64	1.0	0.23	0.25	0.64	-0.45	-0.45	0.81	0.95	-0.45	0.93	0.87		0.75	0.92	0.7	-0.45	0.61
Net Invested Capital	0.87	0.7	0.85	0.97	0.79	-0.76	-0.79	0.48	0.82	0.71	-0.09	-0.01	0.82	-0.53	-0.53	0.63	0.78	-0.53	0.81	0.9	0.75		0.8	0.85	-0.73	0.83
Property Plant And Equipment Gross	0.74	0.89	0.65	0.92	1.0	-0.46	-0.96	0.79	0.57	0.91	0.12	0.16	0.57	-0.73	-0.73	0.74	0.9	-0.73	0.84	0.95	0.92	0.8		0.63	-0.59	0.54
Total Current Assets	0.98	0.74	1.0	0.8	0.62	-0.97	-0.7	0.42	1.0	0.68	0.36	0.44	1.0	-0.36	-0.36	0.73	0.59	-0.36	0.75	0.78	0.7	0.85	0.63		-0.28	0.99
Capital Stock	-0.33	-0.3	-0.28	-0.71	-0.58	0.16	0.47	-0.32	-0.24	-0.4	0.7	0.65	-0.24	0.38	0.38	-0.19	-0.66	0.38	-0.53	-0.59	-0.45	-0.73	-0.59	-0.28		-0.26
Net Working Capital	0.95	0.65	0.99	0.75	0.53	-0.99	-0.62	0.31	1.0	0.58	0.33	0.41	1.0	-0.32	-0.32	0.65	0.5	-0.32	0.68	0.72	0.61	0.83	0.54	0.99	-0.26

Click cells to compare fundamentals

In8bio Account Relationship Matchups

In8bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.1M	20.9M	42.2M	33.0M	33.7M	25.1M
Total Current Liabilities	647K	2.6M	2.3M	5.8M	5.4M	3.1M
Total Stockholder Equity	(346K)	18.3M	38.2M	22.7M	24.9M	19.9M
Property Plant And Equipment Net	274K	186K	2.8M	10.3M	8.6M	9.0M
Net Debt	(610K)	(17.8M)	(34.6M)	(12.3M)	(16.4M)	(17.2M)
Retained Earnings	(9.5M)	(18.0M)	(32.7M)	(61.2M)	(91.2M)	(86.7M)
Accounts Payable	560K	620K	395K	2.1M	924K	918.3K
Cash	610K	18.0M	37.0M	18.2M	21.3M	18.3M
Non Current Assets Total	367K	2.8M	3.2M	10.8M	9.1M	5.0M
Non Currrent Assets Other	93K	2.6M	158K	381K	511K	687.7K
Cash And Short Term Investments	610K	18.0M	37.0M	18.2M	21.3M	18.3M
Liabilities And Stockholders Equity	1.1M	20.9M	42.2M	33.0M	33.7M	25.1M
Other Current Assets	48K	150K	3.9M	7.9M	3.3M	2.8M
Other Stockholder Equity	238K	1.5M	70.9M	83.9M	116.2M	122.0M
Total Liab	1.5M	2.6M	4.0M	10.3M	8.8M	5.2M
Net Invested Capital	(9.2M)	(16.4M)	38.2M	22.7M	24.9M	26.2M
Property Plant And Equipment Gross	274K	186K	3.2M	10.3M	9.9M	10.3M
Total Current Assets	763K	18.1M	39.0M	22.2M	24.6M	20.1M
Net Working Capital	116K	15.6M	36.7M	16.4M	19.2M	17.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:

How To Invest In In8bio

Details

Is In8bio Stock a good investment?

Details

What is In8bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.74)

Return On Assets

(0.78)

Return On Equity

(1.80)

The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

In8bio Reconciled Depreciation vs Net Income From Continuing Ops Analysis

Reconciled Depreciation vs Net Income From Continuing Ops

Reconciled Depreciation vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Reconciled Depreciation

Net Income From Continuing Ops

In8bio fundamental ratios Correlations

In8bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

In8bio fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Net Working Capital	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Assets Total

Net Working Capital	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Other Stockholder Equity	- 0.98	Retained Earnings
Total Current Assets	- 0.97	Net Debt
Property Plant And Equipment Gross	- 0.96	Retained Earnings